• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈发育异常和原位癌的电凝透热疗法:一项为期15年的调查。

Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey.

作者信息

Chanen W, Rome R M

出版信息

Obstet Gynecol. 1983 Jun;61(6):673-9.

PMID:6843923
Abstract

The present report assesses 15 years' experience with electrocoagulation diathermy in the treatment of cervical intraepithelial neoplasia (CIN). Selection is based on the ability to visualize the boundaries of the lesion colposcopically. Visualization, together with cytology and target biopsy, should exclude invasive carcinoma. Histologically confirmed CIN of varying severity (almost two thirds were CIN III) was treated by diathermy in 1864 patients. The size of the lesion varied, and at times the lesion extended into the endocervical canal. Cervical intraepithelial neoplasia was eradicated in 97.3% of patients by a single diathermy treatment. Ninety-three percent of all patients under the age of 30 with CIN were treated by this method. Progression to invasive carcinoma after diathermy has not been demonstrated. A single treatment with electrocoagulation diathermy has proved consistently to be the most effective superficial ablative method for primary eradication of CIN whether deep, extensive, or of major severity.

摘要

本报告评估了电凝透热疗法治疗宫颈上皮内瘤变(CIN)15年的经验。选择该疗法的依据是能够在阴道镜下清晰显示病变边界。阴道镜检查、细胞学检查及靶向活检相结合应能排除浸润癌。1864例经组织学确诊为不同严重程度CIN(近三分之二为CIN III)的患者接受了透热疗法治疗。病变大小各异,有时病变会延伸至宫颈管内。单次透热疗法使97.3%的患者宫颈上皮内瘤变得以根除。所有30岁以下CIN患者中,93%采用了该方法治疗。尚未证实透热疗法后会进展为浸润癌。事实证明,无论CIN病变是深部、广泛还是严重,单次电凝透热疗法始终是原发性根除CIN最有效的浅表消融方法。

相似文献

1
Electrocoagulation diathermy for cervical dysplasia and carcinoma in situ: a 15-year survey.宫颈发育异常和原位癌的电凝透热疗法:一项为期15年的调查。
Obstet Gynecol. 1983 Jun;61(6):673-9.
2
Electrocoagulation diathermy for the treatment of cervical dysplasia and carcinoma in situ.电凝透热疗法治疗宫颈发育异常和原位癌。
Obstet Gynecol. 1976 Feb;47(2):196-9.
3
Role of cryosurgery in the treatment of intraepithelial neoplasia of the uterine cervix.冷冻手术在子宫颈上皮内瘤变治疗中的作用。
Obstet Gynecol. 1981 Jul;58(1):83-7.
4
Accuracy of the diagnosis in suspected intraepithelial neoplasia of the cervix.宫颈疑似上皮内瘤变诊断的准确性。
Ann Chir Gynaecol. 1984;73(1):45-9.
5
Cryosurgical treatment of cervical intraepithelial neoplasia.宫颈上皮内瘤变的冷冻手术治疗
Obstet Gynecol. 1980 Aug;56(2):231-3.
6
[Long-term follow-up of patients after a single-freezing treatment of ectocervical intraepithelial neoplasms].[宫颈上皮内瘤变单次冷冻治疗后患者的长期随访]
Ugeskr Laeger. 1990 Nov 26;152(48):3614-6.
7
[Diathermy excision using a metal loop in the treatment of cervical intra-epithelial neoplasms; short-term results in 154 patients].
Ned Tijdschr Geneeskd. 1992 Nov 7;136(45):2227-31.
8
[Cervical intraepithelial neoplasia. Terminology, diagnosis and treatment].
Tidsskr Nor Laegeforen. 1989 Apr 10;109(10):1052-5.
9
Abnormal cervical cytology in pregnancy: a 17-year experience.妊娠期宫颈细胞学异常:17年经验总结
Obstet Gynecol. 1993 Jun;81(6):915-8.
10
Electrocoagulation and the risk of cervical neoplasia.电凝与宫颈肿瘤形成的风险。
Obstet Gynecol. 1985 Nov;66(5):703-7.

引用本文的文献

1
A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan.日本单家医疗机构行热凝消融治疗高级别宫颈上皮内瘤变患者的前瞻性临床试验。
Sci Rep. 2024 Feb 1;14(1):2632. doi: 10.1038/s41598-024-53197-8.
2
Genital wart virus infections: nuisance or potentially lethal?生殖器疣病毒感染:是麻烦还是有潜在致命性?
Br Med J (Clin Res Ed). 1984 Mar 10;288(6419):735-7. doi: 10.1136/bmj.288.6419.735.
3
Risk of subsequent cytological abnormality and cancer among women with a history of cervical intraepithelial neoplasia: a comparative study.
Cancer Causes Control. 1990 Sep;1(2):143-8. doi: 10.1007/BF00053165.